9 months ago
VSTM
Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Fate Therapeutics IncFATE | +383.57% | $19.36 | $93.62 | 2019-12-30 - 2020-12-30 | Strong Buy |
Fate Therapeutics IncFATE | +182.31% | $2.60 | $7.34 | 2023-11-20 - 2024-03-27 | Strong Buy |
Forty Seven IncFTSV | +172.63% | $34.66 | $94.48 | 2019-12-10 - 2020-03-04 | Strong Buy |
Iovance Biotherapeutics IncIOVA | +167.55% | $5.27 | $14.10 | 2023-09-15 - 2024-03-27 | Strong Buy |
Autolus Therapeutics PLCAUTL | +164.22% | $2.04 | $5.39 | 2023-03-08 - 2024-03-07 | Strong Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Arcus Biosciences IncRCUS | 4 | Strong Buy | $42.00 | +130.64% | Maintains | 2 months ago |
Xencor IncXNCR | 2 | Strong Buy | $50.00 | +123.02% | Maintains | 2 months ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $45.00 | +95.06% | Initiates Coverage On | 3 months ago |
Kura Oncology IncKURA | 1 | Strong Buy | $26.00 | +22.82% | Initiates Coverage On | 3 months ago |
Incyte CorpINCY | 4 | Hold | $77.00 | +34.80% | Maintains | 3 months ago |
Erasca IncERAS | 3 | Strong Buy | $7.00 | +239.81% | Maintains | 4 months ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $8.00 | +8.99% | Maintains | 4 months ago |
Leap Therapeutics IncLPTX | 5 | Strong Buy | $12.00 | +331.65% | Maintains | 4 months ago |
Iovance Biotherapeutics IncIOVA | 4 | Strong Buy | $30.00 | +112.77% | Reiterates | 6 months ago |
Verastem IncVSTM | 5 | Strong Buy | $36.00 | +204.57% | Reiterates | 7 months ago |
Nektar TherapeuticsNKTR | 3 | Hold | $6.00 | +577.97% | Reiterates | 8 months ago |
Corvus Pharmaceuticals IncCRVS | 4 | Hold | $3.50 | +95.53% | Reiterates | 9 months ago |
Neurogene IncNGNE | 3 | Hold | $7.50 | -84.77% | Maintains | a year ago |
In8bio IncINAB | 2 | Strong Buy | $12.00 | +891.74% | Reiterates | a year ago |
Immuneering CorpIMRX | 2 | Strong Buy | $20.00 | +723.05% | Upgrades | a year ago |
Merck & Co IncMRK | 2 | Strong Buy | $130.00 | -1.33% | Reiterates | a year ago |
Cytomx Therapeutics IncCTMX | 3 | Hold | $2.00 | N/A | Maintains | a year ago |
Tcr2 Therapeutics IncTCRR | 1 | Hold | $1.72 | N/A | Downgrades | a year ago |
Autolus Therapeutics PLCAUTL | 2 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Adaptimmune Therapeutics PLCADAP | 2 | Strong Buy | $9.00 | N/A | Upgrades | a year ago |
Effector Therapeutics IncEFTR | 1 | Strong Buy | $500.00 | N/A | Initiates Coverage On | 2 years ago |
Kadmon Holdings IncKDMN | 1 | Hold | $9.50 | N/A | Downgrades | 3 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 4 years ago |
Array Technologies IncARRY | 3 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Celldex Therapeutics IncCLDX | 1 | Hold | $45.00 | N/A | Maintains | 6 years ago |
Ayala Pharmaceuticals IncADXS | 1 | Strong Buy | $6,000.00 | N/A | Maintains | 6 years ago |
Ardelyx IncARDX | 1 | Strong Buy | $14.00 | N/A | Maintains | 6 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Hold | $9.00 | N/A | Maintains | 7 years ago |
Progenics Pharmaceuticals IncPGNX | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 7 years ago |
Oncomed Pharmaceuticals IncOMED | 1 | Hold | $6.00 | N/A | Downgrades | 7 years ago |